Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹2,909.3 Cr | ₹3,128 Cr | ₹3,246 Cr | ₹3,251 Cr |
| Net Profit | ₹498.3 Cr | ₹548 Cr | ₹591 Cr | ₹635 Cr |
| EPS | — | ₹16.19 | ₹17.45 | ₹18.77 |
| Operating Profit | ₹921.1 Cr | ₹995 Cr | ₹1,043 Cr | ₹1,065 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Biocon Limited | ₹418.50 | +3.70% | 177.4 | ₹67.83K Cr mid Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Dividend - Rs 9 Per Share | DIVIDEND |
| 18 Feb 2026 | Interim Dividend - Rs 29 Per Share | INTERIM_DIVIDEND |
| 20 Jun 2025 | Dividend - Rs 6 Per Share | DIVIDEND |
| 31 Jan 2025 | Interim Dividend - Rs 26 Per Sh | INTERIM_DIVIDEND |
| 21 Jun 2024 | Dividend - Rs 6 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for TORNTPHARM
View All
Dr Reddy’s pauses weight loss drug on quality fears
Dr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the active pharmaceutical ingredient manufacturing scale-up. The company assures that already supplied market products remain safe for patient use. Torrent Pharmaceuticals and USV Ltd are recalling some semaglutide batches sourced from Dr Reddy's. Commercial supplies are expected to resume after the issue is resolved and validation is complete.
Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's notice
Torrent Pharmaceuticals is voluntarily recalling select batches of its Semalix semaglutide injection pens. This action follows a product recall notification from its manufacturer, Dr. Reddy's Laboratories. Patient safety remains of paramount importance to the company during this process. There is no risk to patients currently using this specific treatment. All other Semaglutide products sold by Torrent remain unaffected.
Torrent Pharma among 6 stocks to hit 52-week highs & rally up to 25% in a month
Despite a sharp sell-off in the broader market, six BSE 200 stocks touched fresh 52-week highs, highlighting resilient investor confidence. The outperformers from retail, pharmaceuticals and energy sectors continued to show strong momentum, signalling sustained buying interest despite market volatility.